Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 81.45

-1.6%

Dec 29 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2582)	2/4/2010 10:04:32 AM
From: Jibacoa	Read Replies (1) of 3722

CYCC is up 20,71% after Roth Capital analysts initiated coverage with a buy rating and a target of $7.And also a positive report from InvestorSoup.<g> The stock opened with a good UG and it has drifted down some on account of the general market.<g> bigcharts.marketwatch.com Volume is now > 3,600,000 but still below its ADV.<g> As previously mentioned, CYCC has no significant LTD and less than 25M shrs out and it has plenty of room to run.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next